These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 2971018)
1. Maternal levels of pregnancy-specific beta 1-glycoprotein (SP-1) are elevated in pregnancies affected by Down's syndrome. Bartels I; Lindemann A Hum Genet; 1988 Sep; 80(1):46-8. PubMed ID: 2971018 [TBL] [Abstract][Full Text] [Related]
2. Maternal serum specific beta 1-glycoprotein in pregnancies associated with Down's syndrome. Wald N; Cuckle H; Densem J Lancet; 1989 Aug; 2(8660):450. PubMed ID: 2569631 [No Abstract] [Full Text] [Related]
3. Low levels of amniotic fluid pregnancy specific beta-1-glycoprotein in Down's syndrome. Kelly AJ; Wathen NC; Rice A; Iles RK; Ind TE; Chard T Early Hum Dev; 1994 Jun; 37(3):175-8. PubMed ID: 7925075 [TBL] [Abstract][Full Text] [Related]
4. Variation in the levels of pregnancy-specific beta-1-glycoprotein in maternal serum from chromosomally abnormal pregnancies. Graham GW; Crossley JA; Aitken DA; Connor JM Prenat Diagn; 1992 Jun; 12(6):505-12. PubMed ID: 1387478 [TBL] [Abstract][Full Text] [Related]
5. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy. Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718 [TBL] [Abstract][Full Text] [Related]
6. Pregnancy specific beta 1-glycoprotein and human chorionic gonadotrophin levels n amniotic fluid and maternal serum in the first half of pregnancy. Heikinheimo M; Seppälä M; Brock DJ Oncodev Biol Med; 1980 Aug; 1(1):71-6. PubMed ID: 6974343 [TBL] [Abstract][Full Text] [Related]
7. Pregnancy-specific beta 1-glycoprotein in amniotic fluid in high risk late pregnancy. Heikinheimo M Oncodev Biol Med; 1980; 1(4-5):287-90. PubMed ID: 6974344 [TBL] [Abstract][Full Text] [Related]
8. Second-trimester cancer antigen 125 and Down's syndrome. Van Blerk M; Smitz J; De Catte L; Kumps C; Van der Elst J; Van Steirteghem AC Prenat Diagn; 1992 Dec; 12(12):1062-6. PubMed ID: 1287642 [TBL] [Abstract][Full Text] [Related]
9. Amniotic fluid alpha-fetoprotein levels during midtrimester of trisomy pregnancies. Hsu JJ; Hseih TT; Liou JD; Soong YK J Formos Med Assoc; 1994 Jun; 93(6):492-6. PubMed ID: 7532053 [TBL] [Abstract][Full Text] [Related]
10. Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels. DiMaio MS; Baumgarten A; Greenstein RM; Saal HM; Mahoney MJ N Engl J Med; 1987 Aug; 317(6):342-6. PubMed ID: 2439909 [TBL] [Abstract][Full Text] [Related]
11. Decreased amniotic fluid leptin levels in the second trimester in Down's syndrome. Choi TY; Kim S; An BM; Jeong SY; Moon HS; Joo BS Fetal Diagn Ther; 2009; 26(4):195-9. PubMed ID: 19940449 [TBL] [Abstract][Full Text] [Related]
12. Amniotic fluid pregnancy-specific beta 1-glycoprotein (SP1) in Meckel's syndrome: a new test for prenatal diagnosis? Heikinheimo M; Aula P; Rapola J; Wahlström T; Jalanko H; Seppälä M Prenat Diagn; 1982 Apr; 2(2):103-8. PubMed ID: 6183654 [No Abstract] [Full Text] [Related]
13. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening. Tsai MS; Huang YY; Hwa KY; Cheng CC; Lee FK J Formos Med Assoc; 2001 May; 100(5):319-25. PubMed ID: 11432311 [TBL] [Abstract][Full Text] [Related]
15. Radioimmunoassay of SP1 (pregnancy-specific beta1-glycoprotein) in maternal blood and in amniotic fluid normal and pathologic pregnancies. Würz H; Geiger W; Künzig HJ; Jabs-Lehmann A; Bohn H; Lüben G J Perinat Med; 1981; 9(2):67-78. PubMed ID: 6787188 [TBL] [Abstract][Full Text] [Related]
16. Biochemical markers of trisomy 21 and the pathophysiology of Down's syndrome pregnancies. Newby D; Aitken DA; Crossley JA; Howatson AG; Macri JN; Connor JM Prenat Diagn; 1997 Oct; 17(10):941-51. PubMed ID: 9358574 [TBL] [Abstract][Full Text] [Related]
17. Schwangerschafts protein 1 (SP1) adds little to the age-related detection of fetal Down syndrome in the first trimester of pregnancy. Kornman LH; Morssink LP; Ten Hoor KA; De Wolf BT; Kloosterman MD; Beekhuis JR; Mantingh A Prenat Diagn; 1998 Oct; 18(10):1086-90. PubMed ID: 9826903 [TBL] [Abstract][Full Text] [Related]
18. Antenatal screening for Down's syndrome. Wald NJ; Kennard A; Hackshaw A; McGuire A J Med Screen; 1997; 4(4):181-246. PubMed ID: 9494915 [TBL] [Abstract][Full Text] [Related]
19. [Evaluation of Down's syndrome screening methods using maternal serum biochemistry in the second trimester pregnancy]. Yu DY; Fu P; Zhang ZH; Wang F; Han MY; Ren HY; Zhao W; Zhang K; Li S; Jiang N Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Jun; 28(3):332-5. PubMed ID: 21644235 [TBL] [Abstract][Full Text] [Related]
20. Second trimester levels of maternal serum inhibin A, total inhibin, alpha inhibin precursor, and activin in Down's syndrome pregnancy. Lambert-Messerlian GM; Canick JA; Palomaki GE; Schneyer AL J Med Screen; 1996; 3(2):58-62. PubMed ID: 8849760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]